Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0R0FU
|
|||
Former ID |
DIB009541
|
|||
Drug Name |
PXS-4159
|
|||
Synonyms |
Membrane copper amine oxidase modulators (asthma), Pharmaxis; SSAO/VAP-1 inhibitors (asthma), Pharmaxis
Click to Show/Hide
|
|||
Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Investigative | [1] | |
Company |
Pharmaxis Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Membrane copper amine oxidase (AOC3) | Target Info | Inhibitor | [1] |
BioCyc | Phenylethylamine degradation I | |||
Spermine and spermidine degradation I | ||||
KEGG Pathway | Glycine, serine and threonine metabolism | |||
Tyrosine metabolism | ||||
Phenylalanine metabolism | ||||
beta-Alanine metabolism | ||||
Metabolic pathways | ||||
Panther Pathway | Phenylethylamine degradation | |||
Pathwhiz Pathway | Beta-Alanine Metabolism |
References | Top | |||
---|---|---|---|---|
REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2767). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.